Clinical Trial Update: Minocycline Hydrochloride in Reducing Chemotherapy Induced Depression and Anxiety in Patients With Stage I-III Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating whether minocycline hydrochloride can reduce chemotherapy-induced depression and anxiety in patients with Stage I-III breast c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anxiety Disorder
• Breast Cancer
• Depressive Disorder

Drugs mentioned

• Minocycline hydrochloride (minocycline hydrochloride)

Snippet

Sponsor: Ohio State University Comprehensive Cancer Center | Conditions: Anxiety Disorder, Depression | Phase 2 | Status: COMPLETED | Results posted: 2025-01-08